Login / Signup

Impact of body composition on outcomes of immune checkpoint inhibitor combination therapy in patients with previously untreated advanced renal cell carcinoma.

Hiroki IshiharaKoichi NishimuraTakashi IkedaHironori FukudaKazuhiko YoshidaJunpei IizukaTsunenori KondoToshio Takagi
Published in: Urologic oncology (2024)
The SFI can be potentially utilized as an effective predictive and prognostic biomarker for first-line ICI combination therapy for advanced RCC.
Keyphrases
  • body composition
  • combination therapy
  • renal cell carcinoma
  • resistance training
  • bone mineral density
  • type diabetes
  • skeletal muscle
  • glycemic control